Ultrastructural findings in human nonalcoholic steatohepatitis

Expert Review of Gastroenterology and Hepatology

Volumn 5, Issue 2, 2011, Pages 141-145

  Jayakumar, Saumya ^a   Guillot, Stacey ^a   Argo, Curtis ^a   Redick, Jan ^a   Caldwell, Stephen ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

autophagosome; endoplasmic reticulum; fat droplets; Mallory Denk body; mitochondria; NASH; ultrastructure

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FAT DROPLET;

CELL ULTRASTRUCTURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM STRESS; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIVER CELL DAMAGE; MALLORY BODY; MOLECULAR BIOLOGY; NONALCOHOLIC FATTY LIVER; PHAGOSOME; PHASE TRANSITION; REVIEW;

ENDOPLASMIC RETICULUM; FATTY LIVER; HUMANS; LIVER; MITOCHONDRIA, LIVER; PHAGOSOMES;

EID: 79954484731     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.11.9     Document Type: Review

References (57)

1. Phillips MJ, Poucell S, Patterson J, Valencia P. The Liver-an Atlas and Text of Ultrastructural Pathology. Raven Press, NY, USA (1987).
2. Crang RFE, Klomparens KL. Artifacts in Biological Electron Microscopy. Plenum Press, NY, USA (1988).
3. Dianzani MU. Uncoupling of oxidative phosphorylation in mitochondria from fatty livers. Biochim. Biophys. Acta 14, 514-532 (1954).
4. Dianzani MU. The content of adenosine polyphosphates in fatty livers. Biochem. J. 65, 116-124 (1957).
5. Serviddio G, Bellanti F, Vendemiale G, Altomare E. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 5(2), 233-244 (2011).
6. Kleiner DE, Brunt EM, Van Natta ML et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histologic scoring system for NAFLD. Hepatology 41, 1313-1321 (2005). (Pubitemid 40770284)
7. Tao GZ, Looi KS, Toivola DM et al. Keratins modulate the shape and function of hepatocyte mitochondria: a mechanism for protection from apoptosis. J. Cell Sci. 122(Pt 21), 3851-3855 (2009).
8. Candipan RC, Sjostrand FS. An analysis of the contribution of the preparatory techniques to the appearance of condensed and orthodox conformations of liver mitochondria. J. Ultrastruct. Res. 89, 281-294 (1984). (Pubitemid 15091607)
9. Schmucker DL, Mooney JS, Jones AL. Stereological analysis of hepatic fne structure in the Fischer 344 rat. J. Cell Biol. 78, 319-337 (1978).
10. Sternlieb I. Mitochondrial and fatty changes in hepatocytes of patients with Wilson's Disease. Gastroenterology 55, 354-362 (1968).
11. Chedid A, Mendenhall CL, Tosch T et al. Signifcance of megamitochondria in alcoholic liver disease. Gastroenterology 90, 1858-1864 (1986). (Pubitemid 16085590)
12. Caldwell SH, Swerdlow RH, Khan EM et al. Mitochondrial abnormalities in NASH. J. Hepatol. 31, 430-434 (1999).
13. Sanyal AJ, Campbell-Sargent C, Mirshani F et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183-1192 (2001). (Pubitemid 32246672)
14. Sternlieb I, Berger JE. Optical diffraction studies of crystalline structures in electron micrographs. J. Cell Biol. 43, 448-455 (1969).
15. Caldwell SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard BL. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am. J. Gastroenterol. 96, 519-525 (2001).
16. Caldwell SH, de Freitas LA, Park SH et al Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis. Hepatology. 49, 1888-1895 (2009).
17. Williams WP, Selstam E, Brain T. X-ray diffraction studies of the structural organization of prolamellar bodies isolated from Zea mays. FEBS Lett. 422, 252-254 (1998). (Pubitemid 28064554)
18. Deng Y, Kohlwein SD, Manella CA. Fasting induces cyanide-resistant respiration and oxidative stress in the amoeba Chaos carolinensis: implications for the cubic structural transition in mitochondrial membranes. Protoplasm 219, 160-167 (2002). (Pubitemid 34592965)
19. Wolf SG, Frenkiel D, Arad T, Finkel SE, Kolter R, Minsky A. DNA protection by stress-induced biocrystallization. Nature 400, 83-85 (1999). (Pubitemid 29315116)
20. Le TH, Caldwell SH, Redick JA et al. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 39, 1423-1429 (2004). (Pubitemid 38569065)
21. Caldwell SH, Patrie JT, Brunt EM et al. Increased mitochondrial crystalline inclusions after 48 weeks of rosiglitazone in human nonalcoholic steatohepatitis (NASH). Hepatology 46, 1101-1107 (2007). (Pubitemid 350144774)
22. Ahishali E, Demir K, Ahishali B et al. Electron microscopic fndings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis? J. Gastroenterol. Hepatol. 25, 619-626 (2010).
23. French SW. Present understanding of the development of Mallory's body. Arch. Pathol. Lab. Med. 107, 445-450 (1983). (Pubitemid 13043091)
24. Strnad P. The cytoskeleton in nonalcoholic steatohepatitis-100 years old but still youthful. Expert Rev. Gastroenterol. Hepatol. 5(2), 167-177 (2011).
25. Denk H, Franke WW, Eckerstorfer R, Schmid E, Kerjaschki D. Formation and involution of Mallory bodies ('alcoholic hyaline') in murine and human liver revealed by immunofourescence microscopy with antibodies to prekeratin. Proc. Natl Acad. Sci. USA 76, 4112-4116 (1979). (Pubitemid 9249034)
26. Zatloukal K, French SW, Stumptner C et al. From Mallory to Mallory-Denk bodies: What, how and why? Exp.Cell Res. 313, 2033-2049 (2007). (Pubitemid 46842981)
27. Strnad P, Zatloukal K, Stumptner C, Kulaksiz H, Denk, H. Mallory-Denk bodies: lessons from keratin-containing hepatic inclusion bodies. Biochim. Biophys. Acta 1782, 764-774 (2008).
28. Stumptner C, Fuchsbichler A, Heid H, Zatloukal K, Denk H. Mallory body-a disease-associated type of sequestosome. Hepatology 35(5), 1053-1062 (2002). (Pubitemid 34454002)
29. Denk H, Stumpter C, Fuchsbichler A, Zatloukal K. Alcoholic and nonalcoholic steatohepatitis: histopathologic and pathogenetic considerations. Pathologe 22, 388-398 (2001). (Pubitemid 33078685)
30. Lackner C, Gogg-Kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J. Hepatol. 48, 821-828 (2008).
31. Caldwell S, Ikura Y, Dias D et al. Hepatocellular ballooning in NASH. J. Hepatol. 53, 719-723 (2010).
32. Arias IM. The hepatocyte organization. In: The Liver: Biology and Pathobiology (2nd Edition). Arias IM, Jacoby WB, Popper H, Schachter D, Shafritz DA (Eds). Raven Press, NY, USA, 9 (1988).
33. Palade, GE. A study of fxation for electron microscopy J. Exp. Med. 95, 285-298 (1952).
34. Cope GH, Williams MA. Quantitative studies on the preservation of choline and ethanolamine phosphatides during tissue preservation for electron microscopy I. Glutaraldehyde, osmium tetroxide, araldite methods. J. Microsc. 90, 31-46 (1969).
35. Ohsaki Y, Cheng J, Suzuki M, Fujita A, Fujimoto T. Lipid droplets are arrested in the ER membrane by tight binding of lipidated apolipoprotein B-100. J. Cell Sci. 121(Pt 14), 2415-2422 (2008).
36. Anderson N, Borlak J. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol. Rev. 60, 311-357 (2008).
37. Robenek H, Hofnagel O, Buers I, Robenek MJ, Troyer D, Severs NJ. Adipophilin-enriched domains in the ER membrane are sites of lipid droplet biogenesis. J. Cell Sci. 119, 4215-4224 (2006). (Pubitemid 44774028)
38. Fujimoto T, Ohsaki Y, Cheng J, Suzuki M, Shinohara Y Lipid droplets: a classic organelle with new outfts. Histochem. Cell Biol. 130, 263-279 (2008).
39. Imai Y, Varela GM, Jackson MB, Graham MJ, Crooke RM, Ahima RS. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. Gastroenterology 132, 1947-1954 (2007). (Pubitemid 46677941)
40. Dalen KT, Ulven SM, Arntsen BM, Solaas K, Nebb HI. PPAR α activators and fasting induce the expression of adipose differentiation-related protein in liver. J. Lipid Res. 47, 931-943 (2006). (Pubitemid 43778694)
41. Ikura Y, Ohsawa M, Suekane T et al. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology 43, 506-514 (2006).
42. Straub BK, Stoeffel P, Heid H, Zimbelmann R, Schirmacher P. Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis. Hepatology 47, 1936-1946 (2008). (Pubitemid 351945561)
43. Fujii H, Ikura Y, Arimoto J et al. Perilipin, adipophilin and oxidized phosphatidylcholine in human nonalcoholic steatohepatitis. J. Atheroscler. Thromb. 16, 893-901 (2009).
44. Franke WW, Hergt M, Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate flament cage around lipid globules. Cell 49, 131-141 (1987).
45. Welte MA, Cermelli S, Griner J et al. Regulation of lipid-droplet transport by the perilipin homolog LSD2. Curr. Biol. 15, 1266-1275 (2005). (Pubitemid 41026592)
46. Heid HW, Moll R, Schwetlick I, Rackwitz HR, Keenan TW. Adipophilin is a specifc marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 294, 309-321(1998). (Pubitemid 28486407)
47. Robenek H, Robenek M, Troyer D. PAT family proteins pervade lipid droplet cores. J. Lipid Res. 46, 1331-1338 (2005). (Pubitemid 43109848)
48. Boström P, Rutberg M, Ericsson J et al. Cytosolic lipid droplets increase in size by microtubule-dependent complex formation. Arterioscler. Thromb. Vasc. Biol. 25, 1945-1951 (2005). (Pubitemid 41243467)
49. Olofsson SO, Boström P, Andersson L, Rutberg M, Perman J, Borén J. Lipid droplets as dynamic organelles connecting storage and effux of lipids. Biochim. Biophys. Acta 1791, 448-458 (2009).
50. He S, McPhaul C, Li JZ et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 285, 6706-6715 (2010).
51. Cheng J, Fujita A, Ohsaki Y, Suzuki M, Shinohara Y, Fujimoto T Quantitative electron microscopy shows uniform incorporation of triglycerides into existing lipid droplets. Histochem. Cell Biol. 132, 281-291 (2009).
52. Rautao PE, Mansouri A, Lebrec D, Durand F, Valla D, Moreau R. Autophagy in liver diseases. J. Hepatol. 53, 1123-1134 (2010).
53. Singh R, Kausik S, Wang Y et al. Autophagy regulates lipid metabolism. Nature 458, 1131-1135 (2009).
54. Singh R, Xiang Y, Wang Y et al. Autophagy regulates adipose mass and differentiation in mice. J. Clin. Invest. 119, 3329-3339 (2009).
55. Czaja, MJ. Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications. Am. J. Physiol. Cell Physiol. 298, C973-C978 (2010).
56. Inami Y, Yamashina S, Izumi K et al. Lipid accumulation inhibits autophagy in mouse liver (abstract). Presented at: The 60th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2009. Boston, MA, USA, 30 October-3 November 2009. Hepatology 50, 1168A (2009).
57. Glazer HP, Osipov RM, Clements RT, Selke FW, Bianchi C. Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling. Cell Cycle 8, 1738-1746 (2009).